Cureveda Receives NIH Grants for Systemic Sclerosis and COPD Drug
COPD, News, Scleroderma
Biotechnology company Cureveda LLC just announced that it has received two National Institutes of Health (NIH) Phase I Small Business Technology Transfer (STTR) grants worth $450,000 in total. Cureveda specializes in ... Read more